Buprenorphine as a Treatment for Major Depression and Opioid Use Disorder
保存先:
Namchuk, A.B., et al., Buprenorphine as a Treatment for Major Depression and Opioid Use Disorder. Adar, volume 2, 2022, p. 1-16.
Ref.
588688
配架場所:
SIIS Archivo
Palabras clave:
Trastornos, Discapacidad, Depresión, Salud mental, Unión Europea
Trastornos, Discapacidad, Depresión, Salud mental, Unión Europea
抄録:
Rates of major depressive disorder (MDD) are disproportionally high in subjects with opioid use disorder (OUD) relative to the general population. MDD is often more severe in OUD patients, leading to compliance issues with maintenance therapies and poor outcomes
Rates of major depressive disorder (MDD) are disproportionally high in subjects with opioid use disorder (OUD) relative to the general population. MDD is often more severe in OUD patients, leading to compliance issues with maintenance therapies and poor outcomes
このレコードへの初めてのコメントを付けませんか!